GENFIT

GENFIT (EPA:GNFT)

24/01/2023 22:10

GENFIT Announces 2023 Financial Calendar

Voir tous les communiqués de GENFIT

GENFIT (EPA:GNFT)

05/01/2023 22:10

GENFIT to Participate in Upcoming Investor Conferences

Voir tous les communiqués de GENFIT

GENFIT (EPA:GNFT)

17/11/2022 22:10

GENFIT Pipeline Day Highlights Diverse Product Portfolio in Underserved Liver Diseases

Voir tous les communiqués de GENFIT

GENFIT (EPA:GNFT)

10/11/2022 22:10

GENFIT Reports Third Quarter 2022 Financial Information

Voir tous les communiqués de GENFIT

GENFIT (EPA:GNFT)

25/10/2022 22:10

GENFIT Announces Compelling Results for Next-Generation Non-Invasive Diagnostic Technology NIS2+™ in NASH to be Presented at the AASLD Liver Meeting®

Voir tous les communiqués de GENFIT

GENFIT (EPA:GNFT)

29/09/2022 22:10

GENFIT Announces Signature of the Share Purchase Agreement and the Completion of its Acquisition of Versantis

Voir tous les communiqués de GENFIT

GENFIT (EPA:GNFT)

13/09/2022 22:10

FDA Grants GENFIT’s GNS561 Orphan Drug Designation for the Treatment of Cholangiocarcinoma

Voir tous les communiqués de GENFIT

GENFIT (EPA:GNFT)

08/07/2022 22:10

GENFIT: Half-Year Report of Liquidity Contract with Crédit Industriel et Commercial

Voir tous les communiqués de GENFIT

GENFIT (EPA:GNFT)

25/05/2022 22:10

GENFIT: May 25, 2022 Combined Shareholders Meeting results

Voir tous les communiqués de GENFIT

GENFIT (EPA:GNFT)

11/05/2022 22:10

GENFIT Reports First Quarter 2022 Financial Information (Unaudited financial information under IFRS)

Voir tous les communiqués de GENFIT

1
2
3
4
5
6
»